vs
Side-by-side financial comparison of Avery Dennison (AVY) and Organon & Co. (OGN). Click either name above to swap in a different company.
Avery Dennison is the larger business by last-quarter revenue ($2.3B vs $1.5B, roughly 1.5× Organon & Co.). Avery Dennison runs the higher net margin — 7.3% vs -13.6%, a 20.9% gap on every dollar of revenue. On growth, Avery Dennison posted the faster year-over-year revenue change (7.0% vs -5.3%). Avery Dennison produced more free cash flow last quarter ($104.4M vs $96.0M). Over the past eight quarters, Avery Dennison's revenue compounded faster (1.4% CAGR vs -3.6%).
Avery Dennison Corporation is an American multinational manufacturer and distributor of pressure-sensitive adhesive materials, apparel branding labels and tags, RFID inlays, and specialty medical products. The company is a member of the Fortune 500 and is headquartered in Mentor, Ohio.
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
AVY vs OGN — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.3B | $1.5B |
| Net Profit | $168.1M | $-205.0M |
| Gross Margin | 28.9% | 49.2% |
| Operating Margin | 10.7% | -9.8% |
| Net Margin | 7.3% | -13.6% |
| Revenue YoY | 7.0% | -5.3% |
| Net Profit YoY | 1.1% | -288.1% |
| EPS (diluted) | — | $-0.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $2.3B | — | ||
| Q4 25 | $2.3B | $1.5B | ||
| Q3 25 | $2.2B | $1.6B | ||
| Q2 25 | $2.2B | $1.6B | ||
| Q1 25 | $2.1B | $1.5B | ||
| Q4 24 | $2.2B | $1.6B | ||
| Q3 24 | $2.2B | $1.6B | ||
| Q2 24 | $2.2B | $1.6B |
| Q1 26 | $168.1M | — | ||
| Q4 25 | $166.4M | $-205.0M | ||
| Q3 25 | $166.3M | $160.0M | ||
| Q2 25 | $189.0M | $145.0M | ||
| Q1 25 | $166.3M | $87.0M | ||
| Q4 24 | $174.0M | $109.0M | ||
| Q3 24 | $181.7M | $359.0M | ||
| Q2 24 | $176.8M | $195.0M |
| Q1 26 | 28.9% | — | ||
| Q4 25 | 28.7% | 49.2% | ||
| Q3 25 | 28.7% | 53.5% | ||
| Q2 25 | 28.8% | 54.8% | ||
| Q1 25 | 28.9% | 55.6% | ||
| Q4 24 | 27.9% | 56.3% | ||
| Q3 24 | 28.7% | 58.3% | ||
| Q2 24 | 29.6% | 58.4% |
| Q1 26 | 10.7% | — | ||
| Q4 25 | 9.1% | -9.8% | ||
| Q3 25 | 10.6% | 15.2% | ||
| Q2 25 | 11.5% | 14.4% | ||
| Q1 25 | 10.6% | 6.7% | ||
| Q4 24 | 11.0% | 8.1% | ||
| Q3 24 | 11.0% | 13.1% | ||
| Q2 24 | 10.7% | 14.6% |
| Q1 26 | 7.3% | — | ||
| Q4 25 | 7.3% | -13.6% | ||
| Q3 25 | 7.5% | 10.0% | ||
| Q2 25 | 8.5% | 9.1% | ||
| Q1 25 | 7.7% | 5.8% | ||
| Q4 24 | 8.0% | 6.8% | ||
| Q3 24 | 8.3% | 22.7% | ||
| Q2 24 | 7.9% | 12.1% |
| Q1 26 | — | — | ||
| Q4 25 | $2.16 | $-0.78 | ||
| Q3 25 | $2.13 | $0.61 | ||
| Q2 25 | $2.41 | $0.56 | ||
| Q1 25 | $2.09 | $0.33 | ||
| Q4 24 | $2.17 | $0.42 | ||
| Q3 24 | $2.25 | $1.38 | ||
| Q2 24 | $2.18 | $0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $255.1M | $574.0M |
| Total DebtLower is stronger | $3.2B | $8.6B |
| Stockholders' EquityBook value | $2.3B | $752.0M |
| Total Assets | $9.0B | $12.9B |
| Debt / EquityLower = less leverage | 1.38× | 11.49× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $255.1M | — | ||
| Q4 25 | $202.8M | $574.0M | ||
| Q3 25 | $536.3M | $672.0M | ||
| Q2 25 | $215.9M | $599.0M | ||
| Q1 25 | $195.9M | $547.0M | ||
| Q4 24 | $329.1M | $675.0M | ||
| Q3 24 | $212.7M | $763.0M | ||
| Q2 24 | $208.8M | $704.0M |
| Q1 26 | $3.2B | — | ||
| Q4 25 | $3.2B | $8.6B | ||
| Q3 25 | $3.2B | $8.8B | ||
| Q2 25 | $2.6B | $8.9B | ||
| Q1 25 | $2.6B | $9.0B | ||
| Q4 24 | $2.6B | $8.9B | ||
| Q3 24 | $2.0B | $8.7B | ||
| Q2 24 | $2.0B | $8.7B |
| Q1 26 | $2.3B | — | ||
| Q4 25 | $2.2B | $752.0M | ||
| Q3 25 | $2.2B | $906.0M | ||
| Q2 25 | $2.2B | $733.0M | ||
| Q1 25 | $2.2B | $542.0M | ||
| Q4 24 | $2.3B | $472.0M | ||
| Q3 24 | $2.4B | $493.0M | ||
| Q2 24 | $2.3B | $144.0M |
| Q1 26 | $9.0B | — | ||
| Q4 25 | $8.8B | $12.9B | ||
| Q3 25 | $8.9B | $13.6B | ||
| Q2 25 | $8.6B | $13.5B | ||
| Q1 25 | $8.4B | $13.2B | ||
| Q4 24 | $8.4B | $13.1B | ||
| Q3 24 | $8.5B | $12.8B | ||
| Q2 24 | $8.3B | $12.2B |
| Q1 26 | 1.38× | — | ||
| Q4 25 | 1.43× | 11.49× | ||
| Q3 25 | 1.45× | 9.74× | ||
| Q2 25 | 1.19× | 12.14× | ||
| Q1 25 | 1.19× | 16.52× | ||
| Q4 24 | 1.11× | 18.81× | ||
| Q3 24 | 0.85× | 17.75× | ||
| Q2 24 | 0.89× | 60.11× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $141.0M |
| Free Cash FlowOCF − Capex | $104.4M | $96.0M |
| FCF MarginFCF / Revenue | 4.5% | 6.4% |
| Capex IntensityCapex / Revenue | — | 3.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $869.1M | $538.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $376.8M | $141.0M | ||
| Q3 25 | $312.1M | $264.0M | ||
| Q2 25 | $208.8M | $220.0M | ||
| Q1 25 | $-16.3M | $75.0M | ||
| Q4 24 | $351.2M | $390.0M | ||
| Q3 24 | $270.1M | $141.0M | ||
| Q2 24 | $197.7M | $332.0M |
| Q1 26 | $104.4M | — | ||
| Q4 25 | $309.7M | $96.0M | ||
| Q3 25 | $276.2M | $218.0M | ||
| Q2 25 | $178.8M | $181.0M | ||
| Q1 25 | $-52.3M | $43.0M | ||
| Q4 24 | $281.7M | $335.0M | ||
| Q3 24 | $227.1M | $99.0M | ||
| Q2 24 | $150.2M | $300.0M |
| Q1 26 | 4.5% | — | ||
| Q4 25 | 13.6% | 6.4% | ||
| Q3 25 | 12.5% | 13.6% | ||
| Q2 25 | 8.1% | 11.4% | ||
| Q1 25 | -2.4% | 2.8% | ||
| Q4 24 | 12.9% | 21.0% | ||
| Q3 24 | 10.4% | 6.3% | ||
| Q2 24 | 6.7% | 18.7% |
| Q1 26 | — | — | ||
| Q4 25 | 3.0% | 3.0% | ||
| Q3 25 | 1.6% | 2.9% | ||
| Q2 25 | 1.4% | 2.4% | ||
| Q1 25 | 1.7% | 2.1% | ||
| Q4 24 | 3.2% | 3.5% | ||
| Q3 24 | 2.0% | 2.7% | ||
| Q2 24 | 2.1% | 2.0% |
| Q1 26 | — | — | ||
| Q4 25 | 2.26× | — | ||
| Q3 25 | 1.88× | 1.65× | ||
| Q2 25 | 1.10× | 1.52× | ||
| Q1 25 | -0.10× | 0.86× | ||
| Q4 24 | 2.02× | 3.58× | ||
| Q3 24 | 1.49× | 0.39× | ||
| Q2 24 | 1.12× | 1.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AVY
| Materials Group | $1.6B | 72% |
| Solutions Group | $649.2M | 28% |
OGN
Segment breakdown not available.
